Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study

Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study

Active, not recruiting · NCT07008508 · Registry updated 2025-06-06

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Incidence of Venous Thromboembolism and Cardiovascular Events in Breast Cancer Patients Undergoing Cyclin-dependent Kinase 4/6 Inhibitors: The Breast Cancer Associated Vascular Events During Cyclin-dependent Kinase 4/6 Inhibitors Therapy (BRAVE-Cyclin) Study	Embolism and Thrombosis, Neoplasms by Site, Skin and Connective Tissue Diseases, Thromboembolism, breast cancer, breast disorder, breast neoplasm, cardiovascular disorder, neoplasm, skin disorder, vascular disorder, venous thromboembolism	Active, not recruiting	Not stated	2025-06-06		NCT07008508

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	491

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fondazione Policlinico Universitario Agostino Gemelli IRCCS	Rome	Italy	2